A Part of the University of Maryland Medical Center

Connect with UMGCC
Facebook Twitter YouTube Blog iPhone
Email PageEmail page Print PagePrint page

Home >Information for Patients > Dictionary Index

Dictionary of Cancer Terms

View in Spanish: Régimen de tositumomab regular seguido de tositumomab con yodo I 131

Tositumomab and iodine I 131 tositumomab (TAH-sih-TOO-moh-mab I-oh-dine TAH-sih-TOO-moh-mab)
A combination of monoclonal antibodies used to treat certain types of non-Hodgkin lymphoma. The monoclonal antibody tositumomab is given with iodine I 131 tositumomab (a form of tositumomab that has been chemically changed by adding radioactive iodine). Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Also called Bexxar regimen, iodine I 131 tositumomab, and tositumomab.

Source: National Cancer Institute Dictionary of Cancer Terms, available at www.cancer.gov/dictionary.